Essential health benefits benchmark plan review; members of stakeholder work group.
Summary
SB 774 updates Virginia law governing review of the state’s essential health benefits benchmark plan, which is the baseline set of health insurance benefits used for individual and small-group coverage under federal Affordable Care Act rules. The bill requires the State Corporation Commission, working through the Bureau of Insurance, to review the benchmark plan in 2025 and every five years thereafter. Before each review, the Bureau must convene a stakeholder work group with expertise in health plan design, actuarial science, population health, patient advocacy, and assistance for enrollees in individual or small-group coverage.
The work group must examine factors such as denial rates for uncovered benefits, use of mandated benefits, projected medical need and disease burden, and the projected cost of proposed mandates. The Bureau must also assess any referred legislation the Commission chooses to consider and estimate the effect of adding proposed mandates on health coverage costs. The Commission then follows a timeline for deciding whether to seek a benchmark change, obtaining actuarial analysis, holding public hearings, and ultimately recommending any changes to the General Assembly in bill form. The Bureau must also maintain a public website with benchmark review information.
Impact
The bill amends and reenacts Virginia Code § 30-343.1 to formalize and expand the process for reviewing the state’s essential health benefits benchmark plan. It does not itself change covered benefits, but it creates a structured, recurring review process with stakeholder input, actuarial analysis, public hearings, and Commission recommendations to the General Assembly. The measure affects the State Corporation Commission, the Bureau of Insurance, health insurers in the individual and small-group markets, consumers, and advocates for mandated health benefits.
Sentiment
The bill appears to have been broadly supported and noncontroversial. It passed the Senate and House overwhelmingly, with unanimous or near-unanimous votes at each recorded stage and no recorded opposition votes. The voting history suggests general agreement that the benchmark review process should be updated and made more transparent and participatory.
Contention
No major contention is evident in the available record. The main policy questions embedded in the bill concern which stakeholders should participate in the work group, what data should guide review of proposed mandates, and how to balance expanded benefits against premium and coverage-cost impacts. Those issues typically pit consumer and patient advocates, who may favor broader coverage, against insurers, actuaries, and cost-conscious policymakers focused on affordability and market impact.